Morningstar

Pharma

Novo Nordisk, Gilead, BMS, AZ will feel IRA pinch: analysts

Among major biopharma companies, Novo Nordisk, Gilead, Bristol Myers, AstraZeneca and AbbVie will be most affected by the new Inflation Reduction Act.

Kevin Dunleavy Sep 26, 2022 8:57am

Pfizer, Merck, J&J well-positioned for M&A: report

Feb 20, 2019 10:49am